Mgen Solutions Co., Ltd. (KOSDAQ:032790)

Ligand Pharmaceuticals Revenue

Mgen Solutions had revenue of 10.31B KRW in the quarter ending March 31, 2025, with 98.80% growth. This brings the company's revenue in the last twelve months to 47.79B, up 2,300.04% year-over-year. In the year 2024, Mgen Solutions had annual revenue of 42.67B with 106.18% growth.

• Revenue (ttm): 47.79B
• Revenue Growth: +2,300.04%
• P/S Ratio: 0.97
• Revenue / Employee: 549.33M
• Employees: 87
• Market Cap: 46.28B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	42.67B	21.97B	106.18%
Dec 31, 2023	20.70B	-89.10B	-81.15%
Dec 31, 2022	109.79B	38.34B	53.66%
Dec 31, 2021	71.45B	20.34B	39.79%
Dec 31, 2020	51.11B	-373.30M	-0.73%